SCHEMBL12799393

SCHEMBL12799393

COc1cc(N)c(C(=O)Nc2ccc(N)cc2)c(OC)c1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ NPC1 O15118 8/20 0.46
▸ MEN1 O00255 5/20 0.46
▸ KMT2A Q03164 5/20 0.46
▸ SMN1; SMN2 Q16637 7/20 0.45
▸ RAB9A P51151 7/20 0.45
▸ TP53 P04637 5/20 0.45
▸ ALOX15 P16050 1/20 0.45
▸ LMNA P02545 1/20 0.45
▸ POLB P06746 1/20 0.45
▸ PKM P14618 1/20 0.45
▸ APEX1 P27695 1/20 0.45
▸ TDP1 Q9NUW8 1/20 0.45
▸ ALDH1A1 P00352 3/20 0.45
▸ KDM1A O60341 1/20 0.44
▸ MAPT P10636 2/20 0.44
▸ CASP3 P42574 1/20 0.44
▸ SENP8 Q96LD8 1/20 0.44
▸ SENP7 Q9BQF6 1/20 0.44
▸ SENP6 Q9GZR1 1/20 0.44
▸ HDAC8 Q9BY41 2/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14013167 0.93 NPC1 (0.54) NPC1MEN1KMT2ASMN1; SMN2RAB9A
SCHEMBL1663386 0.89 MEN1 (0.51) NPC1MEN1KMT2ASMN1; SMN2ALDH1A1
SCHEMBL14176439 0.84 SMN1; SMN2 (0.50) NPC1MEN1KMT2ASMN1; SMN2RAB9A
SCHEMBL10426957 0.84 MEN1 (0.51) NPC1MEN1KMT2ASMN1; SMN2RAB9A
SCHEMBL14176438 0.82 SMN1; SMN2 (0.51) NPC1MEN1KMT2ASMN1; SMN2RAB9A
SCHEMBL14176441 0.79 MAPT (0.55) NPC1MEN1KMT2ASMN1; SMN2RAB9A
SCHEMBL31710349 0.78 MEN1 (0.60) NPC1MEN1KMT2ASMN1; SMN2RAB9A
SCHEMBL14176435 0.77 MAPT (0.56) NPC1MEN1KMT2ASMN1; SMN2RAB9A
SCHEMBL11303092 0.77 CYP3A4 (0.60) NPC1MEN1KMT2ASMN1; SMN2RAB9A
SCHEMBL13936249 0.77 KLKB1 (0.56) NPC1MEN1KMT2ASMN1; SMN2RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2305652-A2 Trisubstituted quinazolinone derivatives as vanilloid antagonists Novartis AG (CH) 2011-04-06 — — EP disclosed
Send feedback